Hormone Imbalance in Women

PCOS is one of the most common hormonal disorders in women of reproductive age, affecting an estimated 6-12% of women in the United States. It involves elevated androgen (testosterone) levels, irregular ovulation, and often insulin resistance. PCOS disrupts the normal estrogen-progesterone cycle and is a leading driver of infertility, irregular periods, acne, and weight gain in younger women.

Perimenopause typically begins in the mid-to-late 40s, though it can start as early as the late 30s. During this transition, ovarian estrogen and progesterone production becomes erratic before declining significantly. Most women associate hormone imbalance with menopause, but the hormonal volatility of perimenopause often produces more intense symptoms (irregular cycles, sleep disruption, mood swings, and hot flashes) precisely because levels are fluctuating rather than consistently low.

When the body is under sustained stress, the adrenal glands prioritize cortisol production. This comes at a cost: the body uses progesterone as a precursor to make cortisol, a process sometimes called “cortisol steal.” The result is chronically low progesterone relative to estrogen, driving anxiety, poor sleep, and cycle irregularities even in women whose stress feels manageable.

The thyroid gland regulates metabolism, body temperature, heart rate, and mood. Hypothyroidism (underactive thyroid) and Hashimoto’s thyroiditis are significantly more common in women than men. According to the American Thyroid Association, women are 5 to 8 times more likely than men to develop thyroid disorders. Thyroid imbalance often mimics and compounds sex hormone imbalance, making comprehensive testing essential.

Chemicals found in plastics, pesticides, personal care products, and food packaging can mimic or block estrogen in the body. Research published through MedlinePlus identifies these endocrine-disrupting compounds as a growing contributor to hormonal disruption in women of all ages.

Hormonal contraceptives suppress the body’s natural hormone production. When a woman stops taking the pill, her body can take months to resume normal ovulatory function. During this window, estrogen and progesterone levels are often low or erratic, producing symptoms that can be mistaken for a new condition rather than recognized as a predictable transition.

A standard physical looks at fewer than 20 markers, enough to catch disease but not enough to explain why you feel the way you do. Nava runs a full panel across hormones, thyroid, metabolism, inflammation, and cardiovascular health, then retests as your plan progresses so you can see what’s actually changing. Your results live in one place, tracked over time, not scattered across portals from three different offices.

Most lab results end with a recommendation to eat better. Yours ends with a registered dietitian who has read your panel and builds nutrition, supplementation, and lifestyle guidance around what your specific markers show. It’s a full hour, and it adjusts as your labs move.

You work with the same board-certified physician, not whoever is available that week. They know your history, what you’ve already tried, and how your body responded to the last change, which is what makes the next decision a better one. Every result is interpreted by a clinician, never an algorithm.

Any doctor can write you a prescription. Finding the dose that actually works for your body takes follow-up labs, honest conversation about how you feel, and a provider willing to adjust rather than leave you on a starting dose indefinitely. If your plan includes treatment, that refinement process is built in.

Questions don’t wait for your next appointment. Message your care team through the Nava app when something changes, a side effect shows up, or you need to make sense of a result. You’ll get a response from someone who already knows your case.

Estrogen is a potent cardiovascular protector. It supports healthy LDL cholesterol levels, promotes vasodilation, reduces arterial inflammation, and maintains the elasticity of blood vessel walls. When estrogen declines, these protections erode. Research published in PMC confirms that the incidence of cardiovascular disease in postmenopausal women significantly exceeds that of men of the same age, a pattern that tracks directly with estrogen loss.

Timing matters here. A landmark analysis of the “timing hypothesis” found that women who begin hormone therapy within the first 10 years of menopause show a 24% reduction in coronary heart disease risk compared to those who delay treatment. Women who wait more than 10 years after menopause see no cardiovascular benefit and may face increased risk. This is not an argument for rushing into treatment. It is an argument for early evaluation.

Estrogen plays a central role in maintaining bone mineral density by slowing the activity of osteoclasts, the cells that break down bone tissue. When estrogen falls, bone resorption accelerates. According to the CDC, approximately 10 million Americans have osteoporosis, and women account for 80% of those cases. The majority of postmenopausal bone loss occurs in the first 5-7 years after menopause, a window when intervention can make a significant structural difference.

Low progesterone is a direct and measurable cause of poor sleep. Progesterone metabolizes into allopregnanolone, a neurosteroid that acts on GABA-A receptors in the brain, the same receptors targeted by sleep medications. Published research in the Journal of Clinical Endocrinology and Metabolism confirmed that micronized progesterone improves sleep onset latency and total sleep time in postmenopausal women. When progesterone drops, the brain loses a key sleep-regulating compound.

Testosterone in women is not a secondary hormone. It drives lean muscle synthesis, insulin sensitivity, and mitochondrial efficiency. Suboptimal testosterone accelerates visceral fat accumulation and reduces the body’s ability to build and maintain metabolically active muscle — which is why weight gain in hormone-imbalanced women is so resistant to diet and exercise alone.

Estrogen also has neuroprotective properties, supporting the production of acetylcholine and serotonin in the brain. Declining estrogen is associated with increased brain fog, memory lapses, and elevated risk of cognitive decline in longitudinal research.

Treating hormone imbalance is not about chasing symptoms. It is about protecting your cardiovascular system, skeleton, metabolism, and brain before the damage compounds. The earlier an imbalance is identified and addressed, the wider the window for meaningful long-term protection.